Whitepaper challenges WHO stance on e-cigarettes.

Jan.05.2023
Whitepaper challenges WHO stance on e-cigarettes.
A white paper criticizes the WHO's opposition to the e-cigarette movement. THR experts refute the gateway theory to smoking.

A whitepaper has criticized the World Health Organization's (WHO) opposition to the e-cigarette movement. Nancy Loucas, the Executive Coordinator of the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA), stated that the document greatly helps to expose the WHO's misleading rhetoric aimed at smokers and decision-makers.


Nancy Loucas stated that "this white paper completely discredits and refutes the prevalent notion among young people that e-cigarettes are a gateway to smoking.


After compiling and publishing the book "Disrupting Public Health: A Consumer Perspective," several leading international experts in tobacco harm reduction (THR) criticized the World Health Organization's stance, which attracted considerable attention from readers and the media. Her commentary was among those critiques.


Over the past decade, there has been a significant increase in e-cigarette use among high schoolers and young people. However, fortunately, there has been a significant decrease in e-cigarette use since reaching its peak in 2019. During the same period, smoking rates have continued to decline to record lows. The authors of a new report suggest that these trends contradict using e-cigarettes as a gateway to smoking.


The document points out that e-cigarettes among adolescents and young adults are a legitimate concern. However, it provides a comprehensive reference for doctors, researchers, and government funding agencies, all of whom refute any claims about the gateway theory.


The white paper provides a wealth of the latest information on e-cigarette patterns among American youth and young adults. There is no doubt that e-cigarettes are a gateway to smoking, not a slope," said Ms. Loucas.


According to the Centers for Disease Control and Prevention (CDC), the youth e-cigarette rate in the United States has been steadily declining since 2020. CDC data shows that over the past two years, youth e-cigarette use has plummeted by 60%. The white paper states that only 3.1% of high school-aged students and 0.3% of middle school-aged students use e-cigarettes on a daily basis.


We are simply demanding regulations based on evidence and objective policy discussions, decisions, and risk assessment. In November 2023, the world will witness the tenth session of the Conference of the Parties, where attention will be focused on the World Health Organization and many international representatives, whether they will finally start accepting evidence instead of perpetuating the stigma against safer nicotine products," said Ms. Loucas.


Recently, nine member organizations of CAPHRA wrote letters to FCTC delegates from around the world, as well as health ministers and leaders, urging them to review evidence supporting THR methods before COP10.


The tenth meeting of the Conference of the Parties (COP10) will be held in Panama and hosted by the World Health Organization's Framework Convention on Tobacco Control (FCTC).


We will continue to disseminate and challenge key aspects of the World Health Organization's recommendations to the signatories and representatives of the FCTC, regarding the most effective tools for smoking cessation," said Nancy Loucas.


Ms. Loucas presented "Subverting Public Health: A Consumer's Perspective" at the recent 5th Asia Harm Reduction Forum (AHRF 2022).


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Special Report|FDA Revises Device Name in Glas Vape Authorization; Company Signals Optimism on Menthol, Flavored Pods
Special Report|FDA Revises Device Name in Glas Vape Authorization; Company Signals Optimism on Menthol, Flavored Pods
The FDA updated public records on the PMTA authorization of a Glas vape product, renaming “Glas G Device” to “Glas G² Device” and releasing the order letter detailing scientific review and marketing restrictions. Company disclosures suggest the platform may include age-verification technology. If confirmed, Glas G² could be the first vape with device-level age verification to receive an FDA MGO. Glas executives also said menthol and other flavored pods could gain authorization in the future.
Special Report
Mar.14
Philip Morris Ukraine Says It Will Invest Another USD 10.00 Million in ZYN Nicotine Pouches This Year
Philip Morris Ukraine Says It Will Invest Another USD 10.00 Million in ZYN Nicotine Pouches This Year
Philip Morris said that after investing USD 5.00 million last year to promote its ZYN nicotine pouch brand in Ukraine, it plans to invest another USD 10.00 million this year to develop the nicotine pouch category and launch a new ZYN line.
Apr.08 by 2FIRSTS.ai
Russian Duma Speaker Says Amendment Giving Regions Power to Ban Vape Sales Is Planned for Adoption in May
Russian Duma Speaker Says Amendment Giving Regions Power to Ban Vape Sales Is Planned for Adoption in May
Russian State Duma Speaker Vyacheslav Volodin said an amendment that would give Russian regions the power to ban vape sales is planned for adoption in May. Volodin said the decision concerns the health of citizens, especially children. He also said doctors have recorded a 30% increase in patients with respiratory diseases caused or aggravated by vape use, with adolescents and people under 35 most often affected.
Apr.24 by 2FIRSTS.ai
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
The U.S. Food and Drug Administration (FDA) announced on May 5, 2026 that it authorized the marketing of four Glas electronic nicotine delivery system (ENDS) products through the premarket tobacco product application (PMTA) pathway. The authorized products are Classic Menthol, Fresh Menthol, Gold and Sapphire pods, each containing 50mg/ml, or 5%, tobacco-derived nicotine.
May.06 by 2FIRSTS.ai
PML Expands Its UK Smoke-Free Portfolio With LEVIA
PML Expands Its UK Smoke-Free Portfolio With LEVIA
Philip Morris Limited has launched LEVIA, a new range of zero-tobacco flavored nicotine sticks created for the IQOS ILUMA range. The product expands the company’s smoke-free portfolio in the UK and will initially be available in four variants, including Deep Mint and three capsule-based flavors. LEVIA has a recommended retail price of £5, or about $6.73, based on the European Central Bank’s April 28.
Apr.29 by 2FIRSTS.ai
Bangladesh May Remove E-Cigarette Production and Sales Ban in Tobacco Law Amendment
Bangladesh May Remove E-Cigarette Production and Sales Ban in Tobacco Law Amendment
Bangladesh is preparing amendments to its anti-tobacco ordinance that would remove the ban on the production and sale of e-cigarettes and also delete provisions prohibiting the display of tobacco products at points of sale.
Mar.31 by 2FIRSTS.ai